Form 4: Entrada Therapeutics Insider Sells Shares
Insider Transaction (Form 4)
Mpm Bioventures 2018, L.P. and 2 others reported changes in beneficial ownership of Entrada Therapeutics, Inc. common stock on August 24, 2026.
Summary
- Open-market sale: disposed of 21,623 Common Stock at $7.34 ($158,713) on August 24, 2026; holds 4,359,439 after (Indirect).
- Open-market sale: disposed of 26,522 Common Stock at $7.54 ($199,976) on August 25, 2026; holds 4,332,917 after (Indirect).
- Open-market sale: disposed of 14,569 Common Stock at $7.06 ($102,857) on August 26, 2026; holds 4,318,348 after (Indirect).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $461,546 of stock on the open market.
Insider Transactions
Mpm Bioventures 2018, L.P. — 10% owner
MPM BioVentures 2018 LLC — 10% owner
MPM BioVentures 2018 GP LLC — 10% owner
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-24 | Open-market sale | Common Stock | 21,623 | $7 | $158.7K | 4,359,439 |
| 2026-08-25 | Open-market sale | Common Stock | 26,522 | $8 | $200.0K | 4,332,917 |
| 2026-08-26 | Open-market sale | Common Stock | 14,569 | $7 | $102.9K | 4,318,348 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-24 | Open-market sale (21,623 shares) |
| 2026-08-25 | Open-market sale (26,522 shares) |
| 2026-08-26 | Open-market sale (14,569 shares) |
Keywords
insider transaction, Form 4, TRDA, Entrada Therapeutics, Inc., bearish, Mpm Bioventures 2018, L.P., MPM BioVentures 2018 LLC, MPM BioVentures 2018 GP LLC
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.